Clinical and morphological features of central nervous system tumor with  BCOR  internal tandem duplication

M. A. Senchenko; Сенченко М. А.; M. A. Zaytseva; Зайцева М. А.; L. I. Papusha; Папуша Л. И.; A. V. Panferova; Панферова А. В.; A. N. Phlegontov; Флегонтов А. Н.; A. N. Kislyakov; Кисляков А. Н.; A. V. Tarakanova; Тараканова А. В.; A. E. Druy; Друй А. Е.; D. M. Konovalov; Коновалов Д. М.

doi:10.24287/1726-1708-2023-22-4-16-22

Clinical and morphological features of central nervous system tumor with BCOR internal tandem duplication

Authors: Senchenko M.A.¹, Zaytseva M.A.¹, Papusha L.I.¹, Panferova A.V.¹, Phlegontov A.N.¹, Kislyakov A.N.¹, Tarakanova A.V.¹, Druy A.E.¹, Konovalov D.M.¹
Affiliations:
1. Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
Issue: Vol 22, No 4 (2023)
Pages: 16-22
Section: ORIGINAL ARTICLES
Submitted: 05.01.2024
Accepted: 05.01.2024
Published: 20.12.2023
URL: https://hemoncim.com/jour/article/view/801
DOI: https://doi.org/10.24287/1726-1708-2023-22-4-16-22
ID: 801

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

In 2022, central nervous system (CNS) tumor with BCOR internal tandem duplication (BCOR ITD) was included in the fifth edition of the World Health Organization Classification of Tumors of the CNS as part of the embryonal tumor group. The identification a distinct DNA methylation profile and the presence of a recurrent genetic aberration – BCOR ITD – made it possible to recognize these tumors as a separate entity. In most cases, these tumors occur in children under 5 years of age and are located in the hemispheres of the cerebellum or brain. Since CNS tumor with BCOR ITD is a rare and relatively new tumor entity, it is not yet widely known and can be misdiagnosed. The most common initial diagnosis in patients referred for a second opinion to our reference center is anaplastic/classical medulloblastoma. In this article, we aimed to summarize the characteristic clinical, morphological and immunophenotypic features of CNS tumors with BCOR ITD based on 8 clinical cases confirmed by molecular genetic testing. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology.